Download Docs
Export
Print

GENETAC

90263391 | Trademark

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed Oct. 19, 2020
Serial No. 90263391
Registered Dec. 10, 2024
Registration No. 7,599,711
Interlocutory Attorney TASHIA A BUNCH
Class pharmaceutical preparations for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; therapeutic pharmaceuticals for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; small molecule therapies for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation, all of the foregoing related to therapies that target nucleic acids and modulate gene expression; 005; 006; 018; 044; 046; 051; 052; 100; 101
GENETAC
Case Type Trademark Service mark
Status Registered. The registration date is used to determine when post-registration maintenance documents are due.
Opposition 91272599
Genentech, Inc. v. Design Therapeutics, Inc.
  • Design Therapeutics, Inc.;
  • Genentech, Inc.;
Opposition 90263391
Genentech, Inc., et al. v. Design Therapeutics, Inc.
  • Design Therapeutics, Inc.;
  • Genentech, Inc.;
  • The Marfan Foundation, Inc.;
Last Updated: 8 months, 3 weeks ago
Filing Date # Docket Text